Substance Use Disorders Practice Questions

Q: A patient consuming 120 ml of alcohol daily for the past 12 years is diagnosed with alcohol-dependent syndrome. Which of the following drugs should be avoided in its management?

Disulfiram. **Explanation:** The correct answer is **Disulfiram**. In the management of Alcohol Dependence Syndrome (ADS), the primary goal is to achieve abstinence or reduce craving. However, **Disulfiram** is an aversive agent that works by inhibiting the enzyme **aldehyde dehydrogenase**. This leads to the accumulation of acetaldehyde if alcohol is consumed, causing a distressing "Disulfiram-Ethanol Reaction" (nausea, tachycardia, flushing). The key clinical contraindication for Disulfiram is its use in patients who are **actively consuming alcohol** or have consumed it within the last 12–24 hours. Since the patient in the vignette is currently consuming 120 ml of alcohol daily, initiating Disulfiram would trigger a severe, potentially life-threatening reaction. It should only be started after at least 24 hours of abstinence. **Analysis of Incorrect Options:** * **Phenytoin:** While not a primary treatment for dependence, it is often used to manage alcohol-withdrawal seizures (rum fits). It is not contraindicated. * **Naltrexone:** An opioid antagonist that reduces the "reward" or euphoria associated with drinking. It can be started while the patient is still drinking to help reduce consumption. * **Acamprosate:** A NMDA antagonist/GABA agonist used to maintain abstinence. It is safe and does not cause a reaction with alcohol. **High-Yield Clinical Pearls for NEET-PG:** * **First-line for Craving:** Naltrexone (especially if there is a family history or heavy craving). * **Safe in Liver Disease:** Acamprosate (excreted renally) is preferred over Naltrexone/Disulfiram if transaminases are >3x normal. * **Disulfiram-like reaction:** Also seen with Metronidazole, Griseofulvin, and Cefotetan. * **Wernicke’s Encephalopathy:** Always give Thiamine *before* Glucose in alcoholic patients to prevent precipitating acute neurological symptoms.

Q: All of the following are used for the treatment of morphine dependence except?

Disulfiram. **Explanation:** The treatment of morphine (opioid) dependence involves managing acute withdrawal symptoms and long-term maintenance therapy to prevent relapse. **Why Disulfiram is the correct answer:** **Disulfiram** is an aldehyde dehydrogenase inhibitor used exclusively in the treatment of **Alcohol Dependence**. It creates an aversive reaction (Disulfiram-like reaction) by causing acetaldehyde accumulation if alcohol is consumed. It has no pharmacological role in the management of opioid withdrawal or dependence. **Analysis of Incorrect Options:** * **Methadone (Option A):** A long-acting μ-opioid agonist used for **opioid substitution therapy (OST)**. It prevents withdrawal symptoms and reduces "drug-seeking" behavior due to its long half-life and cross-tolerance with morphine. * **Clonidine (Option B):** An $\alpha_2$ agonist used to manage the **autonomic symptoms** of opioid withdrawal (e.g., hypertension, tachycardia, sweating, and tremors). It reduces the sympathetic overactivity caused by the locus coeruleus during detoxification. * **Naltrexone (Option C):** A long-acting **opioid antagonist** used for relapse prevention. It blocks the reinforcing effects (euphoria) of opioids. It is only started after the patient is completely detoxified to avoid precipitating acute withdrawal. **High-Yield Clinical Pearls for NEET-PG:** * **Buprenorphine:** A partial μ-agonist and κ-antagonist; it is the preferred drug for office-based opioid substitution due to its "ceiling effect" on respiratory depression. * **Naloxone:** The drug of choice for **acute opioid poisoning** (short-acting antagonist). * **Lofexidine:** An $\alpha_{2A}$ agonist recently approved specifically for managing opioid withdrawal symptoms, often preferred over clonidine due to less hypotension.

Q: Which of the following is NOT a feature of caffeine withdrawal?

Hallucinations. Caffeine is a central nervous system (CNS) stimulant that acts primarily as an **adenosine receptor antagonist**. When caffeine intake is abruptly stopped or significantly reduced in a regular user, it leads to a characteristic withdrawal syndrome. **Explanation of the Correct Answer:** * **B. Hallucinations:** Hallucinations are **not** a feature of caffeine withdrawal. Hallucinations are typically associated with withdrawal from CNS depressants (like Alcohol or Benzodiazepines) or intoxication with stimulants/hallucinogens. Caffeine withdrawal symptoms are generally non-psychotic and focus on autonomic and mood disturbances. **Explanation of Incorrect Options:** * **A. Headache:** This is the **most common** and hallmark symptom of caffeine withdrawal. It is caused by cerebral vasodilation following the removal of caffeine’s vasoconstrictive effects. * **C. Depression:** Caffeine withdrawal often manifests as dysphoric mood, irritability, or mild depressive symptoms due to the sudden drop in dopamine and norepinephrine stimulation. * **D. Weight gain:** While not the most prominent symptom, increased appetite and subsequent weight gain are recognized features of caffeine withdrawal (similar to nicotine withdrawal). **High-Yield Clinical Pearls for NEET-PG:** * **Onset:** Symptoms usually begin **12–24 hours** after the last dose. * **Peak Intensity:** Occurs at **1–2 days**. * **Duration:** Symptoms can last for **2–9 days**. * **DSM-5 Criteria:** Requires at least three of the following: Headache, fatigue/drowsiness, dysphoric mood/irritability, difficulty concentrating, and flu-like symptoms (nausea/muscle pain). * **Treatment:** Gradual tapering of caffeine intake is the preferred management strategy.

Q: A 45-year-old alcoholic male presents for deaddiction treatment. He has alcohol-induced hepatitis with other blood parameters within normal limits. Which drug should NOT be chosen for relapse prevention?

Naltrexone. **Explanation:** The core clinical challenge in this question is managing alcohol deaddiction in the presence of **liver pathology (Alcoholic Hepatitis)**. **Why Naltrexone is the correct answer:** Naltrexone is an opioid antagonist used to reduce cravings and the "reward" of drinking. However, it is primarily metabolized by the liver and is known to be **hepatotoxic**. It is strictly contraindicated in patients with acute hepatitis or liver failure. Since the patient has alcohol-induced hepatitis, Naltrexone should NOT be chosen. **Analysis of Incorrect Options:** * **Disulfiram (Option A):** While Disulfiram can be hepatotoxic in rare cases, it is not an absolute contraindication in stable hepatitis compared to Naltrexone. However, in clinical practice, it is used with caution. * **Chlordiazepoxide (Option B):** This is a long-acting benzodiazepine used for managing **acute withdrawal**, not typically for long-term relapse prevention. While it requires hepatic metabolism, it is not the primary drug for "relapse prevention" in this context. * **Acamprosate (Option D):** This is the **drug of choice** for this patient. Acamprosate is excreted unchanged by the kidneys and does not undergo hepatic metabolism, making it safe for patients with liver disease. **High-Yield Clinical Pearls for NEET-PG:** * **Safe in Liver Disease:** Acamprosate (Relapse prevention) and Lorazepam/Oxazepam (Withdrawal management—"**L**iver **O**kay"). * **Safe in Renal Failure:** Naltrexone (Avoid Acamprosate if CrCl <30 ml/min). * **Disulfiram Mechanism:** Inhibits Aldehyde Dehydrogenase, leading to accumulation of Acetaldehyde (causing the Disulfiram-Ethanol Reaction). * **Naltrexone Mechanism:** Blocks $\mu$-opioid receptors; best for reducing "heavy drinking" days.

Q: A patient with a known history of alcohol dependence develops seizures for the first time 12 to 18 hours after their last drink. The LFTs are within normal limits. What is the most appropriate pharmacological treatment for this patient?

Chlordiazepoxide. **Explanation:** The patient is presenting with **Alcohol Withdrawal Seizures** (Rum fits), which typically occur 6–48 hours after the last drink. These are usually generalized tonic-clonic seizures and occur as a result of CNS hyperexcitability due to the sudden removal of alcohol’s GABAergic inhibitory effect. **Why Chlordiazepoxide is correct:** Benzodiazepines (BZDs) are the gold standard for managing alcohol withdrawal. They show cross-tolerance with alcohol, acting on GABA-A receptors to provide a "pharmacological bridge" that prevents withdrawal symptoms and seizures. **Chlordiazepoxide** is a long-acting BZD and is the drug of choice in patients with **normal liver function** (as indicated by normal LFTs in this case) because its long half-life provides a smoother "self-tapering" effect, reducing the risk of breakthrough seizures. **Why other options are incorrect:** * **Phenytoin:** It is **ineffective** for alcohol withdrawal seizures. These seizures are metabolic/withdrawal-related, not epileptic. * **Thiamine:** While essential to prevent Wernicke’s Encephalopathy, it has no anticonvulsant properties and will not stop or prevent withdrawal seizures. * **Lorazepam:** Although a BZD, it is short-acting. It is preferred only if the patient has **liver failure** (since it undergoes direct glucuronidation) or is elderly. Since LFTs are normal here, a long-acting agent is superior. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (General):** Chlordiazepoxide or Diazepam. * **Drug of Choice (Liver Failure/Elderly):** **L**orazepam, **O**xazepam, **T**emazepam (Mnemonic: **LOT**). * **Delirium Tremens:** Occurs 48–96 hours after the last drink; characterized by autonomic instability and clouded consciousness. * **Kindling Effect:** Repeated withdrawal episodes increase the risk and severity of future seizures.

Q: Which one of the following drugs of abuse is most typically associated with the illustrated complication?

Cocaine. ***Cocaine*** - **Chronic intranasal use** causes **vasoconstriction** and **ischemic necrosis** of the nasal septum, leading to **septal perforation**. - The **midline destructive lesion** is a pathognomonic finding of chronic cocaine snorting due to its potent **local anesthetic** and **vasoconstrictive** properties. *Ketamine* - Primarily associated with **ketamine cystitis** (chronic bladder inflammation) rather than nasal complications. - Causes **urinary frequency**, **dysuria**, and **hematuria** with chronic use, not septal perforation. *Heroin* - Characteristic complications include **track marks** from intravenous use and **infective endocarditis**. - Associated with **respiratory depression**, **constipation**, and **infectious complications** rather than nasal septal damage. *Phencyclidine* - Known for causing **dissociative episodes** and **violent behavior** during intoxication. - Complications include **hyperthermia**, **hypertension**, and **psychotic episodes**, not nasal septal perforation.

Q: Withdrawal of which of the following substances causes piloerection?

Morphine. **Explanation:** The correct answer is **Morphine (Option A)**. Morphine is an opioid agonist, and the presence of **piloerection** (goosebumps) is a classic, pathognomonic sign of **opioid withdrawal**. **1. Why Morphine is Correct:** Opioid withdrawal syndrome is characterized by a "rebound" hyperactivity of the central and autonomic nervous systems. When an opioid like morphine is discontinued, the body experiences an over-excitation of the sympathetic nervous system. This leads to symptoms such as: * **Piloerection:** Historically, this gave rise to the term "cold turkey" because the skin resembles that of a plucked turkey. * **Other Autonomic Signs:** Mydriasis (dilated pupils), rhinorrhea, lacrimation, yawning, and diaphoresis. * **Gastrointestinal Distress:** Nausea, vomiting, and diarrhea. **2. Why Other Options are Incorrect:** * **Cannabis (B):** Withdrawal is generally mild, involving irritability, insomnia, and decreased appetite, but does not typically feature autonomic signs like piloerection. * **Smoking/Nicotine (C):** Withdrawal involves cravings, anxiety, and increased appetite, but lacks the severe physical autonomic discharge seen in opioids. * **Alcohol (D):** Alcohol withdrawal is life-threatening and characterized by tremors, tachycardia, seizures, and *delirium tremens*. While it involves sympathetic overactivity, piloerection is not a hallmark sign. **Clinical Pearls for NEET-PG:** * **Mydriasis vs. Miosis:** Opioid **intoxication** causes "pinpoint pupils" (miosis), whereas opioid **withdrawal** causes "blown pupils" (mydriasis). * **Severity:** While opioid withdrawal is extremely painful and distressing ("flu-like" symptoms), it is rarely life-threatening, unlike alcohol or benzodiazepine withdrawal. * **Treatment:** Acute withdrawal is managed with **Clonidine** (alpha-2 agonist to reduce sympathetic flow) or opioid substitutes like **Methadone** and **Buprenorphine**.

Q: Nicotine acts as an agonist for receptors of a particular neurotransmitter. The worsening of cognitive symptoms in persons with mild cognitive impairments who stop smoking is due to the effect on this neurotransmitter.

Acetylcholine. **Explanation:** **1. Why Acetylcholine is Correct:** Nicotine is a potent agonist of **Nicotinic Acetylcholine Receptors (nAChRs)**, which are widely distributed in the central nervous system. These receptors play a critical role in cognitive functions such as attention, learning, and memory. In patients with mild cognitive impairment (MCI) or early Alzheimer’s disease, there is a known deficit in cholinergic transmission. Chronic smoking provides exogenous stimulation of these receptors; therefore, sudden cessation leads to a "cholinergic void," resulting in the acute worsening of cognitive symptoms and attention deficits. **2. Why Other Options are Incorrect:** * **B. Dopamine:** While nicotine causes the release of dopamine in the *nucleus accumbens* (mediating its addictive and rewarding properties), the specific link to cognitive decline upon withdrawal is primarily mediated by the cholinergic system, not the dopaminergic reward pathway. * **C. Neuropeptide Y:** This is involved in appetite regulation and anxiety but is not the primary receptor target for nicotine nor the mediator of its cognitive effects. * **D. Nitric Oxide:** This is a retrograde neurotransmitter involved in long-term potentiation, but nicotine does not act as a direct agonist for nitric oxide receptors. **3. Clinical Pearls for NEET-PG:** * **Receptor Subtype:** The **α4β2** nicotinic receptor subtype is the primary mediator of nicotine dependence. * **Therapeutic Link:** The cognitive-enhancing effect of nicotine is the reason why **Cholinesterase Inhibitors** (like Donepezil) are the mainstay of treatment for Alzheimer’s disease. * **Smoking & Schizophrenia:** Up to 80-90% of patients with Schizophrenia smoke; this is often viewed as "self-medication" to improve cognitive deficits and sensory gating via nAChR stimulation. * **Withdrawal:** Nicotine withdrawal peaks within 24–48 hours and typically lasts 2–4 weeks.

Q: Which is the most commonly abused opioid?

Diacetylmorphine. **Explanation:** **Diacetylmorphine (Heroin)** is the most commonly abused opioid globally and in India. The primary reason for its high abuse potential is its **high lipid solubility**. When injected or inhaled, it crosses the blood-brain barrier much faster than morphine, leading to an intense, rapid "rush" or euphoria. In the brain, it is rapidly deacetylated into morphine, which then acts on the mu-opioid receptors. Its high potency, rapid onset of action, and widespread illicit availability make it the leading substance in opioid use disorders. **Analysis of Incorrect Options:** * **Morphine (Option A):** While it is the gold standard for pain management, it is less lipid-soluble than heroin, resulting in a slower onset of action in the CNS. It is more commonly associated with medical therapeutic use than street abuse. * **Codeine (Option B):** Often found in cough syrups, it is a weaker opioid. While "purple drank" or syrup abuse exists, the scale of addiction does not match that of heroin. * **Fentanyl (Option D):** It is significantly more potent than heroin (50–100 times more than morphine). While it is the leading cause of overdose deaths in North America, globally and statistically in the Indian context, heroin remains the more commonly abused substance. **NEET-PG High-Yield Pearls:** * **Triad of Opioid Poisoning:** Miosis (pinpoint pupils), Respiratory depression, and Altered sensorium (Coma). * **Exception to Miosis:** Pethidine (Meperidine) poisoning causes **mydriasis** due to its atropine-like action. * **Treatment of Choice:** **Naloxone** (IV) is the antagonist for acute overdose; **Methadone** or **Buprenorphine** are used for substitution therapy in long-term management. * **Withdrawal Symptoms:** Characterized by "flu-like" symptoms: lacrimation, rhinorrhea, yawning, piloerection (gooseflesh), and dilated pupils.

Question 1

A 35-year-old man presented with agitation, global confusion, disorientation, hallucinations, and autonomic hyperactivity. He had his last alcohol drink 5 days ago. Which of the following can be used in the immediate treatment of the condition?

Accepted Answer

Chlordiazepoxide

Answer

Diazepam

Answer

Carbamazepine

Answer

Morphine

Question 2

A patient consuming 120 ml of alcohol daily for the past 12 years is diagnosed with alcohol-dependent syndrome. Which of the following drugs should be avoided in its management?

Accepted Answer

Disulfiram

Answer

Phenytoin

Answer

Naltrexone

Answer

Acamprosate

Question 3

All of the following are used for the treatment of morphine dependence except?

Accepted Answer

Disulfiram

Answer

Methadone

Answer

Clonidine

Answer

Naltrexone

Question 4

Which of the following is NOT a feature of caffeine withdrawal?

Accepted Answer

Hallucinations

Answer

Headache

Answer

Depression

Answer

Weight gain

Question 5

A 45-year-old alcoholic male presents for deaddiction treatment. He has alcohol-induced hepatitis with other blood parameters within normal limits. Which drug should NOT be chosen for relapse prevention?

Accepted Answer

Naltrexone

Answer

Disulfiram

Answer

Chlordiazepoxide

Answer

Acamprosate

Question 6

A patient with a known history of alcohol dependence develops seizures for the first time 12 to 18 hours after their last drink. The LFTs are within normal limits. What is the most appropriate pharmacological treatment for this patient?

Accepted Answer

Chlordiazepoxide

Answer

Phenytoin

Answer

Thiamine

Answer

Lorazepam

Question 7

Which one of the following drugs of abuse is most typically associated with the illustrated complication?

Accepted Answer

Cocaine

Answer

Ketamine

Answer

Heroin

Answer

Phencyclidine

Question 8

Withdrawal of which of the following substances causes piloerection?

Accepted Answer

Morphine

Answer

Cannabis

Answer

Smoking

Answer

Alcohol

Question 9

Nicotine acts as an agonist for receptors of a particular neurotransmitter. The worsening of cognitive symptoms in persons with mild cognitive impairments who stop smoking is due to the effect on this neurotransmitter.

Accepted Answer

Acetylcholine

Answer

Dopamine

Answer

Neuropeptide Y

Answer

Nitric oxide

Question 10

Which is the most commonly abused opioid?

Accepted Answer

Diacetylmorphine

Answer

Morphine

Answer

Codeine

Answer

Fentanyl

Substance Use Disorders — MCQs

Substance Use Disorders — MCQs

On this page

Practice by Chapter

Want unlimited practice?